TransCure develops humanized mouse platforms in its own state-of-the-art and accredited biosafety level 2 and 3 (BSL2 and BSL3) animal facilities and laboratories, allowing to test infectious and non-infectious diseases such as HIV, HCV, HBV, Tuberculosis, inflammation and auto-immune diseases, rheumatoid arthritis, inflammatory bowel disease , multiple sclerosis, Lupus or parasitic diseases.
Domain: R&D Services and Technology Platforms, CRO (Contract Research Organization)
Therapeutics & Diagnostics, Antibodies / Anti-infectives
Therapeutics & Diagnostics, Cell Therapy / Stem Cells
Therapeutics & Diagnostics, Chemical Drug, small Molecules
Therapeutics & Diagnostics, Gene Therapy
Therapeutics & Diagnostics, Generics / Biosimilars
Therapeutics & Diagnostics, Vaccines
Contact: Av. de la Praille 26
1227 Carouge / GE
P: 079 955 64 56

http://www.transcurebiosciences.com
Find an actor

Journée de l'Innovation 2017 aux HUG Jeudi 19 octobre19.10.2017

11ème Journée de l’innovation au Centre de l’innovation des HUG. Conférences, concours de pitchs, remise des...

Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round

Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn